Business Description
Resverlogix Corp. is a Canadian biotechnology company based in Calgary that focuses on developing treatments for patients living with serious long-term health conditions. Its main drug, apabetalone, targets a range of conditions including heart disease, kidney disease, type 2 diabetes, and complications linked to COVID-19. The company works with partners Eversana Life Science Services and Medison Pharma to bring apabetalone to market across North America and beyond.
